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In vitro emulsiﬁcation assessment of new silicone oils
Albert Caramoy, Sabine Schro ¨der, Sascha Fauser, Bernd Kirchhof
ABSTRACT
Aim To investigate whether the emulsiﬁcation of
conventional silicone oils can be reduced by adding small
amounts of silicone molecules of a very long chain
length.
Methods Siluron 1000, Siluron 2000, Siluron 5000, Acri.
Sil-Ol 5000, Oxane 5700, Densiron 68 LV, Densiron 68
and Densiron 68 HV (0.5 ml) were each tested along with
either plasma or serum (0.5 ml) in a glass cuvette.
Emulsiﬁcation was induced by sonication and
documented by photography. The total area of emulsiﬁed
oil was assessed using the ImageJ software.
Results The addition of small amounts of very-long-
chain silicone molecules signiﬁcantly reduced the
emulsiﬁcation for 1000 cSt silicone oil (Siluron 2000) and
for 1000 cSt silicone oil with an admixture of F6H8
(Densiron 68 HV).
Conclusion New low-viscosity silicone oils show
a reduced emulsiﬁcation similar to that of 5000 cSt oils.
In future, it may be possible to avoid using 5000 cSt oils.
The ﬁndings may foster silicone oil surgery in general, and
in particular the application of small-incision techniques.
INTRODUCTION
A major problem inherent in the use of silicone oil
as vitreous tamponades is emulsiﬁcation.
1 Emulsi-
ﬁcation can generate oil droplets that may cause
secondary glaucoma, keratopathy and subjective
disturbances, even after the silicone oil is
removed.
2e5
The emulsiﬁcation of silicone oil is inﬂuenced by
many factors including viscosity and interface
tension.
6 Highly viscous silicone oil tends to be
more stable in terms of emulsiﬁcation than less
viscous oil.
7 Consequently, surgeonsdat least in
Europedprefer high-viscosity silicone oils
(5000 cSt), accepting extended ﬁlling and removal
times. On the other hand, less viscous silicone oils
allow better handling when using small-gauge
instruments (25- or 23-gauge). It is therefore desir-
able to develop silicone oils that are resistant to
emulsiﬁcation and of low viscosity.
Silicone oils are composed of polymers and hence
show the characteristics of non-Newtonian ﬂuids.
This means that the viscosity changes along with
the shear rate. The shear viscosity does not fully
explain the emulsiﬁcation tendency, however. By
mixing a small amount of very-long-chain silicone
molecules into common silicone oil, the extensional
viscosity may be increased while more or less
maintaining the shear viscosity.
8e10 The addition of
very-long-chain silicone molecules increases the
resistance to extensional deformation and therefore
increasing its extensional viscosity. This increases
the resistance to emulsiﬁcation.
11
In this study, using an in vitro test system, we
compared the emulsiﬁcation of new silicone oils
that contain very-long-chain silicone molecules
(Siluron 2000 and Densiron 68 HV) and various
commonly used silicone oils (Siluron 1000, Siluron
5000, Densiron 68 LV, Densiron 68, AcriSil-Ol 5000
and Oxane 5700).
MATERIAL AND METHODS
The different silicone oils were assessed using
a modiﬁcation of an in vitro model originally
developed by Savion et al.
12 In this model, oil
droplets similar in diameter to those in patient eyes
were generated. Two different established emulsi-
ﬁers were used: serum and plasma.
12
Emulsiﬁer preparation
Blood samples were taken in compliance with the
Declaration of Helsinki; informed consent was
obtained. The samples were taken from a young,
healthy male individual on one day. Blood samples
were taken using Sarstedt tubes (S-Monovette,
Sarstedt) ﬁlled with EDTA (for plasma samples) or
with gel platelets (for serum samples). The blood
samples were centrifuged at 1000 g for 10 min at
48C. The supernatant was carefully collected
(not disturbing the buffy coat) and stored at  808C
until use.
Silicone oil compositions
The compositions of the various silicone oils are
summarised in table 1.
Silicone oil emulsiﬁcation procedures
The emulsiﬁer (0.5 ml) was placed into a glass
cuvette with a ﬂat base (inner dimensions:
4310340 mm). Silicone oil (0.5 ml) was added
carefully to allow phase separation. The whole glass
cuvette was then centrifuged at 5000 g to eliminate
air bubbles. Since the emulsiﬁcation procedures
occur in the border between the two phases, no air
bubbles were involved. The following silicone oils
were used: Siluron 1000 (1000 mPas, Lot SIL1
170708), Siluron 2000 (2000 mPas, Lot SIL2
120808), Siluron 5000 (5000 mPas, Lot SIL5
191007), Acri.Sil-Ol 5000 (5000 mPas, Lot 3282),
Oxane 5700 (5700 mPas, Lot 31908), Densiron 68
LV (300 mPas, Lot D68-LV 120207), Densiron 68
(1400 mPas, Lot D68 101207) and Densiron 68 HV
(1300 mPas). Siluron 1000, Siluron 2000, Siluron
5000, Densiron 68 LV, Densiron 68 and Densiron 68
HV were provided by Fluoron GmbH (Neu-Ulm,
Germany). Acri.Sil-Ol 5000 was obtained from Acri.
Tec GmbH (Hennigsdorf, Germany), and Oxane
5700 was obtained from Bausch & Lomb Surgical
(Berlin, Germany).
The test was performed in duplicate for each oil
type and for each emulsiﬁer. For the negative
control, the emulsiﬁer was replaced with distilled
water. The glass cuvette was held in the centre of
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Laboratory sciencea sonication device (Sonorex TK 30, Bandelin). The water in the
sonication device was kept at 20e248C. Sonication was
performed for 3 min to induce emulsiﬁcation. Thereafter, the
glass cuvette was centrifuged at 5000 g for 30 min.
Assessment of the emulsiﬁcation
The emulsiﬁcation was assessed every 10 min after centrifuga-
tion. The cuvette was photographed together with a ruler on its
side, and the amount of emulsiﬁed oil was then measured on the
photograph using the ImageJ software (National Institutes of
Health, Bethesda, Maryland). The ratio of emulsiﬁed silicone oil
was determined by comparing with the whole area of the
aqueous phase, emulsiﬁed oil and non-emulsiﬁed oil. The emul-
siﬁcation area as a percentage was calculated: emulsiﬁcation area
(%)¼(area of emulsiﬁed oil/total area)3100. Total area¼area of
aqueous area+area of emulsiﬁed oil+area of non-emulsiﬁed oil.
Each sample (n¼2) was measured 10 times. The mean ratio was
calculated from all 10 measurements. All data were calculated
from the emulsiﬁcation area after 30 min of centrifugation.
Statistical methods
For statistical analysis, a t test was performed using the NCSS
(number cruncher statistical system) software (version 2004).
The means of all 10 measurements were used. p Values <0.05
were considered to be statistically signiﬁcant. All values are
shown as mean6SD.
RESULTS
In the negative control using distilled water, a small amount of
oil droplets was detected after sonication; the oil droplets
disappeared after centrifugation. After the emulsiﬁcation proce-
dure using silicone oils with an emulsiﬁer, three phases were seen
in the glass cuvettes (ﬁgure 1). An aqueous phase at the bottom,
emulsiﬁed silicone oil in the middle and non-emulsiﬁed silicone
oil on top were seen for Siluron 1000, Siluron 2000, Siluron 5000,
AcriSil-Ol 5000 and Oxane 5700. Heavier-than-water silicone oils
showed non-emulsiﬁed silicone oil at the bottom, emulsiﬁed
siliconeoilin themiddleandan aqueousphaseon top.Duringthe
sonication procedures, the emulsiﬁed oil bubbles are created at
the border between the aqueous and oil phase. No air bubbles
were involved in this process. The emulsiﬁcation area was
assessed every 10 min after centrifugation, and no statistical
difference was found among them. Therefore, all data shown use
the data after 30 min of centrifugation.
Overall, the emulsiﬁcation areas of the silicone oils tested
were higher in the serum than in the plasma group (table 2). The
lowest emulsiﬁcation areas were found for Siluron 2000 in the
serum group (8.2%) and Densiron 68 HV in the plasma group
(2.4%). A summary of the emulsiﬁcation areas in both groups is
presented in ﬁgures 2, 3. The p values of all groups are presented
in ﬁgure 4. Overall, no statistical signiﬁcance was seen between
AcriSil-Ol 5000, Oxane 5700 and Siluron 5000. Compared with
other lighter-than-water silicone oils, Siluron 2000 has less
emulsiﬁcation, which is also statistically signiﬁcant. Densiron 68
HV has also less emulsiﬁcation compared with other heavier-
than-water silicone oils. In the serum group, Densiron 68 HV has
about the same emulsiﬁcation as Siluron 5000 and Oxane 5700.
DISCUSSION
In this study, we present a quantitative analysis of the emulsi-
ﬁcation of silicone oil. We modiﬁed the method originally
developed by Savion et al
12 by using a glass cuvette with a ﬂat
base, which allowed us also to measure heavier-than-water sili-
cone oils. We also determined the area of the emulsiﬁed oils
instead of the height, which increased the precision of the test.
Siluron 5000, Acri.Sil-Ol 5000 and Oxane 5700 are the
tamponade agents most frequently used in Germany and are
considered the standard silicone oils against which all other oils
are tested. Using our in vitro model, there were no statistically
signiﬁcant differences between these three oils with regard to
their emulsiﬁcations (ﬁgure 4). As expected, a signiﬁcantly higher
degree of emulsiﬁcation was found for 1000 cSt silicone oil
(Siluron 1000). This difference was more prominent when using
serum as emulsiﬁer rather than plasma.
The difference between serum and plasma is the content of
thrombocytes. Serum lacks thrombocytes, while plasma does
not. Overall, a slightly higher emulsiﬁcation was seen, using
serum instead of plasma. One explanation for this might be the
activation of the thrombocytes in the serum tubes during the
coagulation process. During this thrombocytes secreted various
coagulation proteins such as serotonin, platelet factor 4, platelet
derived growth factor, ﬁbrinogen, etc. These might serve as an
emulsiﬁer as well, explaining the slightly higher emulsiﬁcation
Table 1 Compositions of various silicone oils
Silicone oil Composition
Siluron 1000 PMDS 1000 mPas (MW 36760 g/mol)
Siluron 2000 5% high-molecular-weight silicone oil
(423 K PMDS)+95% Siluron 1000
Siluron 5000 PMDS 5000 mPas (MW 65025 g/mol)
Acri.Sil-Ol 5000 PMDS 5000 mPas
Oxane 5700 PMDS 5700 mPas
Densiron 68 LV 30.5% SFA+69.5% Siluron 1000
Densiron 68 30.5% SFA+69.5% Siluron 5000
Densiron 68 HV 30.5% SFA+69.5% of (10% Sil 2500000
+90% Siluron 1000)
MW, molecular weight; PMDS, polydimethysiloxane; SFA, semiﬂuorinated alkane.
Figure 1 Emulsiﬁcation of various
silicone oils using plasma as emulsiﬁer.
When testing lighter-than-water silicone
oils, three phases can be seen: non-
emulsiﬁed silicone oil (top), emulsiﬁed
silicone oil (middle) and aqueous phase
(bottom). When testing heavier-than-
water silicone oils, the aqueous phase
was on top, emulsiﬁed silicone oil in the
middle and non-emulsiﬁed oil at the
bottom. Densiron 68 LV emulsiﬁes easily
and somewhat disperses, creating
a hazy appearance, as compared with
prior sonication.
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emulsiﬁcation is still speculative though.
Siluron 2000 (1000 cSt silicone oil plus long-chain silicone oil)
emulsiﬁed signiﬁcantly less than Siluron 1000 (1000 cSt
conventional silicone oil), and even less than Siluron 5000, Acri.
Sil-Ol 5000 and Oxane 5700 (ﬁgures 3, 4). This shows that the
emulsiﬁcation can be reduced by adding very-long-chain silicone
molecules. The shear viscosity of Siluron 1000 (1000 cSt)
increased to 2000 cSt in the case of Siluron 2000.
Most objections against heavier-than-water silicone oil are
based on the higher degree of emulsiﬁcation of Densiron 68
(Siluron 5000+F6H8).
1 13e15 We speculate that the addition of
semiﬂuorinated ﬂuorocarbon not only renders silicone more
hydrophilic but also makes it more susceptible to the splitting off
of small droplets into an aqueous environment. It is fortunate
that the addition of long-chain silicone oil molecules (Densiron
68 HV) to Densiron 68 LV (Siluron 1000+F6H8) signiﬁcantly
reduces emulsiﬁcation compared with either Densiron 68 LV or
Siluron 1000. When compared with the three 5000 cSt oils,
Densiron 68 HV shows about the same emulsiﬁcation in the
serum group but shows a lower emulsiﬁcation in the plasma
group (ﬁgure 4). The shear viscosities of Densiron 68 (1400 mPas)
and Densiron 68 HV (1300 mPas) are rather similar. One may
suggest therefore giving preference to Densiron 68 HV over
Densiron 68; studies on retinal tolerance are pending, however.
The higher the probability of emulsiﬁcation for the conven-
tional silicone oils, the more pronounced was the lowering effect
of adding long chains of silicone. This effect is best shown when
comparing Densiron 68 LV (mixture of Siluron 1000 and F6H8)
with Densiron 68 HV (mixture of Siluron 1000, F6H8, and very-
long-chain silicone molecules). The emulsiﬁcation of Densiron 68
HV is lower, and the difference to Densiron 68 LV is strikingly
signiﬁcant. We conclude that adding small amounts of very-long-
chain silicone oil molecules has a large inﬂuence on reducing the
emulsiﬁcation. The reason for this is the increased extensional
viscosity of a non-Newtonian ﬂuid, which determines the
propensity for emulsiﬁcation.
The in vitro results presented here require veriﬁcation by
future studies using an animal model. Still, some difﬁculties
using animal models for testing emulsiﬁcation and toxicity of
silicone oil are yet to be overcome. In the in vivo model, various
amounts of emulsiﬁers or various intensity of eye movement in
the animal eye might produce different amounts of emulsiﬁca-
tion for the same silicone oil. Also, no objective method is
currently known for quantifying emulsiﬁcation in vivo. In terms
of toxicity, models in some animals, such as rabbits, have been
shown to be inadequate. This is because of the inability to
induce complete posterior vitreous detachment, causing the
retina to be protected from the silicone oil by the rest of the
vitreous.
16 Proper animal models for testing emulsiﬁcation and
toxicity are still to be developed. Nevertheless, we show in this
paper that the emulsiﬁcation of silicone oils can be inﬂuenced by
adding very-long-chain silicone oil. The in vitro model shown in
this paper is even more important, since it shows that with same
amount of emulsiﬁer and same energy used for inducing emul-
siﬁcation, there is less emulsiﬁcation with Siluron 2000 and
Densiron 68 HV than with other silicone oils. This is an impor-
tant step before moving on to in vivo models. Also, in an in vivo
model, different proportions of oil and emulsiﬁers would be
expected.
In conclusion, using an in vitro technique, we quantiﬁed the
emulsiﬁcation of various silicone oils. The method presented in
this study provides a very effective tool for the accurate deter-
mination of emulsiﬁcation and comparison of different silicone
Table 2 Emulsiﬁcation area (%; mean6SD) of silicone oils determined using an in vitro test
Silicone oil
Emulsiﬁer
Siluron
1000
Siluron
2000
Siluron
5000
AcriSil-
Ol 5000
Oxane
5700
Densiron
68 LV
Densiron
68
Densiron
68 HV
Plasma 11.061.7 6.560.4 8.962.0 8.961.8 8.961.6 46.361.6 14.965.7 2.460.5
Serum 16.4611.1 8.261.6 10.061.9 9.960.8 9.662.2 50.362.0 28.761.8 10.560.7
Figure 2 Emulsiﬁcation areas of various silicone oils using plasma as
emulsiﬁer.
Figure 3 Emulsiﬁcation areas of various silicone oils using serum as
emulsiﬁer.
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molecules, the emulsiﬁcation of silicone oil can be reduced, as in
the case of Siluron 2000 and Densiron 68 HV.
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